UNSPSC 51311611: Setastine hydrochloride

This classification denotes a histamine-1 receptor antagonist C22H28ClNO.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T2MB6P84ON, chemically known as setastine hydrochloride, (+/-)-, but more generally known as setastine hydrochloride, which bears US NIH Compound Identifier 43081. European Medicines Agency schedules Setastine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15235MIG.

Most nations, for tariff and trade purposes, schedule setastine hydrochloride under HS 29339930 and SITC 51577. As of Q4 2014, SETASTINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CC(C1CCCCC1)(C2CCC(CC2)CL)OCCN3CCCCCC3.CL.

UNSPSC 51311611 Setastine hydrochloride is a Commodity code, but the recent state and local procurement activity tagged under it does not reflect pharmaceutical procurement of setastine specifically. Seminole County, Florida's IFB60459723LAS (posted June 30, 2026, due July 26, 2023) solicits naloxone and drug deactivation systems—opioid-reversal agents and harm-reduction equipment—rather than setastine hydrochloride, a nonsedating antihistamine. The mismatch between the code's nominal scope and the actual work being bought suggests either a tagging error or that the code captures a broader set of pharmaceutical or medical commodities than its name indicates. The procurement supports community health initiatives with quarterly deliveries to a county health facility, requiring vendors to cover all shipping and delivery costs, maintain drug-free workplace certification and E-Verify compliance, and hold workers' compensation, commercial general liability, and professional liability insurance.

Seminole County is the sole recent issuing body visible in the activity block. The solicitation is structured as a competitive IFB with an initial two-year term plus one optional renewal year and includes a three-month probationary termination-at-will period. Potential FEMA funding introduces federal compliance overlays including the Clean Air Act and Federal Water Pollution Control Act, with auditing and record-inspection provisions. The code shows minimal recent activity at the state and local level for setastine hydrochloride specifically; a business pursuing this code should clarify with procurement offices whether they are seeking the pharmaceutical as tagged or whether the tagging reflects a broader medical-supply or pharmaceutical-category classification.